{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T15:35:57Z","timestamp":1776008157274,"version":"3.50.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Walther Cancer Foundations"},{"DOI":"10.13039\/100007114","name":"Ralph W. and Grace M. Showalter Research Trust Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007114","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Near-Miss Initiative at IUSCCC"},{"name":"Indiana University Simon Comprehensive Cancer Center","award":["NIH\/NCI P30CA082709"],"award-info":[{"award-number":["NIH\/NCI P30CA082709"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["TPA 969255"],"award-info":[{"award-number":["TPA 969255"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Army Medical Research Acquisition Activity, Prostate Cancer Research Program","award":["W81XWH-22-1-0332"],"award-info":[{"award-number":["W81XWH-22-1-0332"]}]},{"name":"U.S. Army Medical Research Acquisition Activity, Prostate Cancer Research Program","award":["W81XWH-16-1-0394"],"award-info":[{"award-number":["W81XWH-16-1-0394"]}]},{"name":"U.S. Army Medical Research Acquisition Activity, Prostate Cancer Research Program","award":["W81XWH-13-1-0398"],"award-info":[{"award-number":["W81XWH-13-1-0398"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL147871"],"award-info":[{"award-number":["R01 HL147871"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA248033"],"award-info":[{"award-number":["R01CA248033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer (PCa) is the most prevalent cancer affecting American men. Castration-resistant prostate cancer (CRPC) can emerge during hormone therapy for PCa, manifesting with elevated serum prostate-specific antigen levels, continued disease progression, and\/or metastasis to the new sites, resulting in a poor prognosis. A subset of CRPC patients shows a neuroendocrine (NE) phenotype, signifying reduced or no reliance on androgen receptor signaling and a particularly unfavorable prognosis. In this study, we incorporated computational approaches based on both gene expression profiles and protein\u2013protein interaction networks. We identified 500 potential marker genes, which are significantly enriched in cell cycle and neuronal processes. The top 40 candidates, collectively named CDHu40, demonstrated superior performance in distinguishing NE PCa (NEPC) and non-NEPC samples based on gene expression profiles. CDHu40 outperformed most of the other published marker sets, excelling particularly at the prognostic level. Notably, some marker genes in CDHu40, absent in the other marker sets, have been reported to be associated with NEPC in the literature, such as DDC, FOLH1, BEX1, MAST1, and CACNA1A. Importantly, elevated CDHu40 scores derived from our predictive model showed a robust correlation with unfavorable survival outcomes in patients, indicating the potential of the CDHu40 score as a promising indicator for predicting the survival prognosis of those patients with the NE phenotype. Motif enrichment analysis on the top candidates suggests that REST and E2F6 may serve as key regulators in the NEPC progression.<\/jats:p>","DOI":"10.1093\/bib\/bbae471","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T16:17:23Z","timestamp":1725985043000},"source":"Crossref","is-referenced-by-count":3,"title":["CDHu40: a novel marker gene set of neuroendocrine prostate cancer"],"prefix":"10.1093","volume":"25","author":[{"given":"Sheng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Medical and Molecular Genetics, Indiana University School of Medicine , 410 W 10th Street, Indianapolis, IN 46202 ,","place":["United States"]}]},{"given":"Hye Seung","family":"Nam","sequence":"additional","affiliation":[{"name":"Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University , 575 Stadium Mall Drive, West Lafayette, IN 47907 ,","place":["United States"]}]},{"given":"Ziyu","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences , Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, , 100 Galvin Life Science Center, Notre Dame, IN 46556 ,","place":["United States"]},{"name":"University of Notre Dame , Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, , 100 Galvin Life Science Center, Notre Dame, IN 46556 ,","place":["United States"]}]},{"given":"Xuehong","family":"Deng","sequence":"additional","affiliation":[{"name":"Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University , 575 Stadium Mall Drive, West Lafayette, IN 47907 ,","place":["United States"]}]},{"given":"Elnaz","family":"Pashaei","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, Indiana University School of Medicine , 410 W 10th Street, Indianapolis, IN 46202 ,","place":["United States"]}]},{"given":"Yong","family":"Zang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Health Data Science, Indiana University School of Medicine , 410 W 10th Street, Indianapolis, IN 46202 ,","place":["United States"]}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Herman B Wells Center for Pediatric Research, , 1044 W Walnut St, Indianapolis, IN 46202 ,","place":["United States"]},{"name":"Indiana University School of Medicine , Herman B Wells Center for Pediatric Research, , 1044 W Walnut St, Indianapolis, IN 46202 ,","place":["United States"]}]},{"given":"Chenglong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry , College of Pharmacy, , 1345 Center Dr Room P3-12, Gainesville, FL 32603 ,","place":["United States"]},{"name":"University of Florida , College of Pharmacy, , 1345 Center Dr Room P3-12, Gainesville, FL 32603 ,","place":["United States"]}]},{"given":"Jiaoti","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Duke University School of Medicine , Davison Building, 40 Duke Medicine, Durham, NC 27710 ,","place":["United States"]}]},{"given":"Michael K","family":"Wendt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine , Division of Hematology and Oncology, , 200 Hawkins Dr, Iowa City, IA 52242 ,","place":["United States"]},{"name":"University of Iowa , Division of Hematology and Oncology, , 200 Hawkins Dr, Iowa City, IA 52242 ,","place":["United States"]},{"name":"Holden Comprehensive Cancer Center, University of Iowa , 200 Hawkins Dr, Iowa City, IA, 52242,","place":["United States"]}]},{"given":"Xin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences , Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, , 100 Galvin Life Science Center, Notre Dame, IN 46556 ,","place":["United States"]},{"name":"University of Notre Dame , Boler-Parseghian Center for Rare and Neglected Diseases, Harper Cancer Research Institute, , 100 Galvin Life Science Center, Notre Dame, IN 46556 ,","place":["United States"]},{"name":"Indiana University Simon Comprehensive Cancer Center, Indiana University School of Medicine , 535 Barnhill Dr, Indianapolis, IN 46202 ,","place":["United States"]}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[{"name":"Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University , 575 Stadium Mall Drive, West Lafayette, IN 47907 ,","place":["United States"]}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-6562","authenticated-orcid":false,"given":"Jun","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, Indiana University School of Medicine , 410 W 10th Street, Indianapolis, IN 46202 ,","place":["United States"]},{"name":"Indiana University Simon Comprehensive Cancer Center, Indiana University School of Medicine , 535 Barnhill Dr, Indianapolis, IN 46202 ,","place":["United States"]},{"name":"Center for Computational Biology and Bioinformatics, Indiana University School of Medicine , 410 W 10th Street, Indianapolis, IN 46202 ,","place":["United States"]}]}],"member":"286","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"2024092505361891900_ref1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"2024092505361891900_ref2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5489\/cuaj.10167","article-title":"Guidelines for the management of castrate-resistant prostate cancer","volume":"4","author":"Saad","year":"2010","journal-title":"Can Urol Assoc J"},{"key":"2024092505361891900_ref3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2024092505361891900_ref4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11912-017-0593-6","article-title":"Emerging variants of castration-resistant prostate cancer","volume":"19","author":"Vlachostergios","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"2024092505361891900_ref5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014","journal-title":"N Engl J Med"},{"key":"2024092505361891900_ref6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat Med"},{"key":"2024092505361891900_ref7","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J Clin Oncol"},{"key":"2024092505361891900_ref8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejca.2019.08.011","article-title":"Clinical features of neuroendocrine prostate cancer","volume":"121","author":"Conteduca","year":"2019","journal-title":"Eur J Cancer"},{"key":"2024092505361891900_ref9","doi-asserted-by":"publisher","first-page":"1609968","DOI":"10.3389\/pore.2021.1609968","article-title":"Identification of novel diagnosis biomarkers for therapy-related neuroendocrine prostate cancer","volume":"27","author":"Zhang","year":"2021","journal-title":"Pathol Oncol Res"},{"key":"2024092505361891900_ref10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1126\/scitranslmed.aav0891","article-title":"Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer","volume":"11","author":"Puca","year":"2019","journal-title":"Sci Transl Med"},{"key":"2024092505361891900_ref11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41585-021-00490-0","article-title":"Molecular events in neuroendocrine prostate cancer development","volume":"18","author":"Wang","year":"2021","journal-title":"Nat Rev Urol"},{"key":"2024092505361891900_ref12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/PAS.0000000000000208","article-title":"Proposed morphologic classification of prostate cancer with neuroendocrine differentiation","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2024092505361891900_ref13","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cels.2020.05.008","article-title":"uKIN combines new and prior information with guided network propagation to accurately identify disease genes","volume":"10","author":"Hristov","year":"2020","journal-title":"Cell Syst"},{"key":"2024092505361891900_ref18","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024092505361891900_ref55","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/1078-0432.CCR-11-1867","article-title":"Modeling a lethal prostate cancer variant with small-cell carcinoma features","volume":"18","author":"Tzelepi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2024092505361891900_ref56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cells9061441","article-title":"Androgen deprivation induces reprogramming of prostate cancer cells to stem-like cells","volume":"9","author":"Sanchez","year":"2020","journal-title":"Cells"},{"key":"2024092505361891900_ref57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cells9061398","article-title":"Conditionally reprogrammed cells from patient-derived xenograft to model neuroendocrine prostate cancer development","volume":"9","author":"Ci","year":"2020","journal-title":"Cells"},{"key":"2024092505361891900_ref58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/gigascience\/giy050","article-title":"The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications","volume":"7","author":"Ramnarine","year":"2018","journal-title":"Gigascience"},{"key":"2024092505361891900_ref15","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1016\/j.csbj.2022.10.031","article-title":"Reprogramming landscape highlighted by dynamic transcriptomes in therapy-induced neuroendocrine differentiation","volume":"20","author":"Asberry","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"2024092505361891900_ref16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","article-title":"Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer","volume":"3","author":"Dong","year":"2020","journal-title":"Commun Biol"},{"key":"2024092505361891900_ref14","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1158\/0008-5472.CAN-23-0593","article-title":"The genomic and Epigenomic landscape of double-negative metastatic prostate cancer","volume":"83","author":"Lundberg","year":"2023","journal-title":"Cancer Res"},{"key":"2024092505361891900_ref17","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"2024092505361891900_ref19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"2024092505361891900_ref20","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2024092505361891900_ref21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2024092505361891900_ref22","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2024092505361891900_ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"2024092505361891900_ref24","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"2024092505361891900_ref25","article-title":"Survminer: drawing survival curves using 'ggplot2'","author":"Kassambara","year":"2019"},{"key":"2024092505361891900_ref26","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"key":"2024092505361891900_ref27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"2024092505361891900_ref28","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1111\/cas.14935","article-title":"Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13","volume":"112","author":"Okasho","year":"2021","journal-title":"Cancer Sci"},{"key":"2024092505361891900_ref29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2024092505361891900_ref30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1186\/s12885-017-3729-z","article-title":"Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma","volume":"17","author":"Tsai","year":"2017","journal-title":"BMC Cancer"},{"key":"2024092505361891900_ref31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","article-title":"Androgen receptor pathway-independent prostate cancer is sustained through FGF Signaling","volume":"32","author":"Bluemn","year":"2017","journal-title":"Cancer Cell"},{"key":"2024092505361891900_ref32","first-page":"327","article-title":"Bioinformatics analyses of publicly available NEPCa datasets","volume":"7","author":"Cheng","year":"2019","journal-title":"Am J Clin Exp Urol"},{"key":"2024092505361891900_ref33","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J Clin Invest"},{"key":"2024092505361891900_ref34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms21031078","article-title":"Gene expression signature predictive of neuroendocrine transformation in prostate adenocarcinoma","volume":"21","author":"Ostano","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024092505361891900_ref35","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/2159-8290.CD-22-0692","article-title":"Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes","volume":"13","author":"De Sarkar","year":"2023","journal-title":"Cancer Discov"},{"key":"2024092505361891900_ref36","first-page":"4078","article-title":"Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin a, and dense core granules in human tumors of endocrine and nonendocrine origin","volume":"48","author":"Gazdar","year":"1988","journal-title":"Cancer Res"},{"key":"2024092505361891900_ref37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1530\/ERC-18-0226","article-title":"Neuroendocrine differentiation of prostate cancer leads to PSMA suppression","volume":"26","author":"Bakht","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2024092505361891900_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110722","article-title":"BEX1 mediates sorafenib resistance in hepatocellular carcinoma by regulating AKT signaling","volume":"108","author":"Zhuang","year":"2023","journal-title":"Cell Signal"},{"key":"2024092505361891900_ref39","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/sj.bjc.6604565","article-title":"Identification of novel neuroendocrine-specific tumour genes","volume":"99","author":"Hofsli","year":"2008","journal-title":"Br J Cancer"},{"key":"2024092505361891900_ref40","doi-asserted-by":"publisher","first-page":"29892","DOI":"10.1074\/jbc.M114.580084","article-title":"Gene targeting study reveals unexpected expression of brain-expressed X-linked 2 in endocrine and tissue stem\/progenitor cells in mice","volume":"289","author":"Ito","year":"2014","journal-title":"J Biol Chem"},{"key":"2024092505361891900_ref41","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/2211-5463.12860","article-title":"MAST1 modulates neuronal differentiation and cell cycle exit via P27 in neuroblastoma cells","volume":"10","author":"Jing","year":"2020","journal-title":"FEBS Open Bio"},{"key":"2024092505361891900_ref42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056362","article-title":"Identification of a novel nonsense mutation p.Tyr1957Ter of CACNA1A in a Chinese family with episodic ataxia 2","volume":"8","author":"Hu","year":"2013","journal-title":"PLoS One"},{"key":"2024092505361891900_ref43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12893-021-01174-7","article-title":"Risk factors for lymph node metastasis in gastric neuroendocrine tumor: a retrospective study","volume":"21","author":"Li","year":"2021","journal-title":"BMC Surg"},{"key":"2024092505361891900_ref44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1530\/ERC-21-0051","article-title":"Prognostic transcriptome classes of duodenopancreatic neuroendocrine tumors","volume":"28","author":"Diedisheim","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"2024092505361891900_ref45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/path.4047","article-title":"From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer","volume":"227","author":"Lapuk","year":"2012","journal-title":"J Pathol"},{"key":"2024092505361891900_ref46","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/MPA.0000000000000944","article-title":"Cell cycle protein expression in neuroendocrine Tumors: association of CDK4\/CDK6, CCND1, and phosphorylated retinoblastoma protein with proliferative index","volume":"46","author":"Shi","year":"2017","journal-title":"Pancreas"},{"key":"2024092505361891900_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100564","article-title":"CDC25B induces cellular senescence and correlates with tumor suppression in a p53-dependent manner","volume":"296","author":"Chen","year":"2021","journal-title":"J Biol Chem"},{"key":"2024092505361891900_ref48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4103\/aja.aja_92_20","article-title":"Identifying the role of apolipoprotein A-I in prostate cancer","volume":"23","author":"Wang","year":"2021","journal-title":"Asian J Androl"},{"key":"2024092505361891900_ref49","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S1470-2045(15)00186-2","article-title":"Consensus on biomarkers for neuroendocrine tumour disease","volume":"16","author":"Oberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"2024092505361891900_ref50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41467-018-08133-6","article-title":"ONECUT2 is a driver of neuroendocrine prostate cancer","volume":"10","author":"Guo","year":"2019","journal-title":"Nat Commun"},{"key":"2024092505361891900_ref51","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3892\/ijmm.2016.2672","article-title":"Identification of NR0B1 as a novel androgen receptor co-repressor in mouse Sertoli cells","volume":"38","author":"Li","year":"2016","journal-title":"Int J Mol Med"},{"key":"2024092505361891900_ref52","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ajhg.2020.06.018","article-title":"Enhanced MAPK1 function causes a neurodevelopmental disorder within the RASopathy clinical Spectrum","volume":"107","author":"Motta","year":"2020","journal-title":"Am J Hum Genet"},{"key":"2024092505361891900_ref53","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1038\/onc.2017.50","article-title":"FOXA1 inhibits prostate cancer neuroendocrine differentiation","volume":"36","author":"Kim","year":"2017","journal-title":"Oncogene"},{"key":"2024092505361891900_ref54","first-page":"273","article-title":"Neuroendocrine differentiation of prostate cancer: a review","volume":"2","author":"Parimi","year":"2014","journal-title":"Am J Clin Exp Urol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/25\/6\/bbae471\/59328457\/bbae471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/25\/6\/bbae471\/59328457\/bbae471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T09:59:08Z","timestamp":1727258348000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbae471\/7774511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9,23]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbae471","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.28.587205","asserted-by":"object"}]},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,9,23]]},"article-number":"bbae471"}}